So-Young International Inc

So-Young International Inc(SY)股票分析

$2.090

+0.105 (+5.03%)收盤時

Loading chart…
最高
2.095
開盤
2.000
成交量加權均價
2.06
成交量
117.81K
市值
106.38M
最低
2.000
成交金額
242.89K
企業價值/稅息折舊攤銷前利潤(TTM)
-0.23

So-Young International Inc is a holding company mainly engaged in online platform for discovering, evaluating and reserving medical aesthetic services. The Company operates its businesses through two segments including So-Young segment and Wuhan Miracle segment. So-Young segment mainly provides information services, reservation services, aesthetic treatment services and sales of medical products and maintenance services. Wuhan Miracle segment is mainly engaged in the research and development, production, sales and agency of laser and other optoelectronic medical equipment. The Company operates across multiple access points, including mobile app, Weixin mini program, and soyoung.com website.

AI 分析 of So-Young International Inc (SY)

持有

So-Young International Inc is not a good buy right now due to its current price of 1.99, which is significantly below its 52-week high of 4.75, and an RSI of 12.45 indicating it is oversold. While the company has shown revenue growth, with Q2 2026 revenue at 505.2 million CNY, a 33% year-over-year increase, it still faces significant net losses, with a net income of -22.7 million CNY in Q2 2026. The main risk is its negative earnings per share of -0.29, which reflects ongoing financial challenges despite some positive revenue trends.

估值指標

So-Young International Inc(SY)目前預期本益比為 16.29,5 年平均預期本益比為 -8.30。

預期本益比

合理
5 年均值 P/E
-8.30
目前P/E
16.29
高估
74.09
低估
-90.69

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
-21.74
目前EV/EBITDA
-0.23
高估
46.57
低估
-90.06

預期股價營收比

低估
5 年均值 P/S
0.63
目前P/S
0.07
高估
1.07
低估
0.19

Alphio AI 對 SY 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%SY

$0.73

情境價格

基

基準

基準 · 50%SY

$0.70

情境價格

悲

悲觀

悲觀 · 25%SY

$0.56

情境價格

持有 SY 的大戶

O

Oasis Management Company Ltd.

+ 持有SY

-12.75%

3個月報酬率

事件時間軸

2026-08-04 (ET)

17:30:00

So-Young International Appoints Nan Shen as CFO

2025-07-03 (ET)

05:57:46

So-Young regains Nasdaq compliance

2025-05-30 (ET)

06:13:54

So-Young plans to implement ADS ratio change

2025-02-27 (ET)

05:51:36

So-Young to transfer listing to Nasdaq Capital

2024-11-20 (ET)

04:29:12

So-Young sees Q4 revenue RMB 350M-RMB 370M

資訊

SY 常見問題 —— 由 Alphio AI 解答

So-Young International Inc is a holding company mainly engaged in online platform for discovering, evaluating and reserving medical aesthetic services. The Company operates its businesses through two segments including So-Young segment and Wuhan Miracle segment. So-Young segment mainly provides information services, reservation services, aesthetic treatment services and sales of medical products and maintenance services. Wuhan Miracle segment is mainly engaged in the research and development, production, sales and agency of laser and other optoelectronic medical equipment. The Company operates across multiple access points, including mobile app, Weixin mini program, and soyoung.com website. It operates in the Consumer Cyclicals sector (COMPUTER PROCESSING AND DATA PREPARATION AND PROCE industry).

So-Young International Inc is not a good buy right now due to its current price of 1.99, which is significantly below its 52-week high of 4.75, and an RSI of 12.45 indicating it is oversold. While the company has shown revenue growth, with Q2 2026 revenue at 505.2 million CNY, a 33% year-over-year increase, it still faces significant net losses, with a net income of -22.7 million CNY in Q2 2026. The main risk is its negative earnings per share of -0.29, which reflects ongoing financial challenges despite some positive revenue trends.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易